A series of experiments were conducted to determine whether and under what conditions central prolactin (PRL) administration would stimulate the onset of maternal behavior in female rats and to identify possible neural sites of PRL action. In each experiment ovariectomized, nulliparous rats whose endogenous PRL levels were suppressed with bromocriptine were tested for maternal behavior toward foster young. In experiments 1, 2, and 4, females were also exposed to pregnancy-like levels of progesterone (days 1-11) followed by estradiol (days 11-17). In experiment 1 infusions (days 11-13) of four doses of ovine PRL (400 ng, 2 ,ug, 10 ,ug, or 50 jug, but not 80 ng) into the lateral ventricle resulted in a rapid onset of maternal behavior (behavioral testing, days 12-17). The stimulatory action of these doses of PRL appears to be central, since subcutaneous injections of 50 jug of ovine PRL failed to affect maternal responsiveness (experiment 2). Experiment 3 indicated that the stimulatory effect of intracerebroventricularly administered PRL is steroid dependent. Infusions of either 10 ,ug of ovine PRL or 10 1ug of rat PRL failed to induce maternal behavior in nonsteroid-treated animals. In the final experiment (no. 4) bilateral infusions of 40 ng of ovine PRL into the medial preoptic area of steroid-treated rats resulted in a pronounced stimulation of maternal behavior. These findings demonstrate a central site of PRL action in the stimulation of maternal responsiveness and point to the medial preoptic area as a key neural site for PRL regulation of maternal behavior.
,ug of ovine PRL or 10 1ug of rat PRL failed to induce maternal behavior in nonsteroid-treated animals. In the final experiment (no. 4) bilateral infusions of 40 ng of ovine PRL into the medial preoptic area of steroid-treated rats resulted in a pronounced stimulation of maternal behavior. These findings demonstrate a central site of PRL action in the stimulation of maternal responsiveness and point to the medial preoptic area as a key neural site for PRL regulation of maternal behavior.
The hormonal changes accompanying pregnancy and parturition play a critical role in preparing the female to respond maternally toward her newborn young (1) (2) (3) (4) . One hormone that recently was shown to have a key role in inducing maternal behavior is the pituitary hormone prolactin (PRL) (5, 6) . PRL and other members of the PRL family-i.e., growth hormone and placental lactogens-are secreted in large amounts during pregnancy (7) (8) (9) , making these molecules potential physiological regulators of maternal behavior. Eliminating or suppressing PRL secretion in steroid-treated, ovariectomized, nulliparous rats by either hypophysectomy or administration of bromocriptine, a dopamine agonist, blocks the rapid onset of maternal behavior (5, 6) . These effects are prevented when PRL is given to hypophysectomized or bromocriptine-treated female rats.
Although PRL stimulates the onset of maternal behavior, little is known about PRL's site of action. The purpose of the present report was to investigate the possibility that PRL acts at the level of the central nervous system to stimulate maternal behavior. A central site of PRL action is feasible in light of a series of findings that indicate that circulating PRL can gain access to the brain through active transport across the blood-cerebrospinal fluid (CSF) barrier (10) , that PRL, presumably of pituitary origin, is found in increased amounts within the CSF at times when circulating levels of PRL are elevated (11) (12) (13) , and that receptors for PRL have been localized within the central nervous system (14) (15) (16) (17) (18) .
In a series of four experiments, we first asked whether direct infusions of PRL into the ventricular system would stimulate the onset of maternal behavior in inexperienced female rats. We then asked whether the actions of PRL were central and under what conditions central PRL administration would stimulate maternal behavior. Finally, the behavioral effects of direct administration of PRL to the medial preoptic area (MPOA), an area known to be involved in the regulation of maternal behavior (19) CD(SD)BR] weighing =200 g were purchased from Charles River Breeding Laboratories. Experimental females were individually housed in 45 x 25 x 20 cm opaque polypropylene test cages that contained -1.5 liters of medium-sized flake wooden shavings. Groups of lactating donor rats were also maintained to provide rat pups for behavioral testing. Animals were housed in light-(on 0500-1900 hr) and temperature-(21-24°C) controlled rooms and provided food (Purina Rat Chow) and water ad libitum.
Animals used in these experiments were maintained in accordance with the standards set forth by the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council (20) .
Cannulations. One week prior to the start of steroid treatment, female rats were fitted either with unilateral guide cannulas (22 gauge; Plastics One, Roanoke, VA) directed toward the right lateral ventricle [DeGroot coordinates: anterior-posterior (AP) = 5.6; lateral (L) = -1.6; horizontal (H) = 3.9] or with 22-gauge bilateral guides directed toward the MPOA (AP = 7.5; L = +1.0; H = 4.0). Dummy cannulas were cut to extend 1 mm beyond the tip of the guide for the ventricular placements and to be flush with the guide cannulas for the MPOA placements. Infusion cannulas (28 gauge) were designed to extend 1 mm beyond the tip of the guide cannula for the ventricular placements (H = 2.9) and 5 mm beyond the tip of the bilateral guides (H = -1.0). All cannulations were performed under general anesthesia (chloropent or ketamine/xylazine). Females were also ovariectomized at the time of cannulation. Steroid Hormone Regimen. The steroid regimen consisted of exposing rats sequentially to progesterone (P) and estradiol (E2; Steraloids, Wilton, NH). Six to 8 days after ovariectomy on treatment day 1, rats were implanted s.c. with three 30-mm P-filled Silastic capsules (Dow Corning tubing no. 602-305; see ref. 6 ). These P capsules were removed between 0900 and 1000 hr on day 11, at which time each rat was given a single 2-mm E2 implant. This hormone regimen was used because it results in a rapid stimulation of maternal behavior in nulliparous rats (6) and mimics changes in steroid concentrations found in pregnant rats (21) . Rats were anesthesized with Metofane when implanting or removing hormone capsules.
Injections. All animals were injected s.c. twice daily at 0900 and 1700 hr from treatment day 11 through 17 (experiments 1, 2, and 4) or on days 1 to 7 (experiment 3) with bromocriptine (Sandoz Pharmaceutical) at a dose of 2 mg/kg. This dose of bromocriptine suppresses endogenous PRL secretion throughout the period of exogenous PRL treatment and behavioral testing (6) .
Infusions. Ovine PRL (oPRL; lots oPRL-18, AFP 8277E and oPRL-19, AFP 9221A) and rat PRL (rPRL; lot rPRL-6, AFP 7545E) were obtained from the National Hormone and Pituitary Program and solubilized in 0.03 M NaHCO3 in 0.15 M NaCl prior to infusions. Specified volumes were infused into the lateral ventricle over 52-58 sec and bilaterally into the MPOA over a 22-sec period with a Sage or Stoelting infusion pump fitted with 10-to 100-pl Hamilton syringes.
Infusion cannulas remained in the guide cannulas for 30-40 sec after each infusion. In all intracerebroventricular (i.c.v.) studies, infusions were performed five times [from 1000 to 1100 hr and again between 1600 and 1700 hr one day before behavioral testing, twice on the first day oftesting (0900-1000 hr and 1600-1700 hr), and a final time between 0900 and 1000 hr on the second test day].
Behavioral Testing. Animals were tested daily for maternal responsiveness beginning on treatment day 12 (or day 2; experiment 3) following previously described procedures (6) . Animals were observed in their home cages for 1 hrcontinuously for 15 min and then at 15-min intervals for the remainder of the hour. Behavioral testing lasted for 6 days or until a female displayed full maternal behavior on 2 consecutive test days, whichever first occurred. Females were scored as fully maternal if they retrieved all three test pups to the nest, grouped them in the nest, and crouched over them within the 60-min test session. The latency of the animal to exhibit a maternal response was based upon the test session in which the response was observed. An animal, for example, that responded on test day 1 was assigned a latency of 0 day.
Histology. At the completion of behavioral testing, rats from experiments 1, 3, and 4 were anesthetized with chloropent, the presence of E2 capsules was validated for steroidtreated animals, and india ink was infused into the lateral ventricle or bilaterally into the MPOA. Rats were then perfused intracardially with physiological saline followed by 10% formalin, and brains were removed and stored in formalin prior to sectioning. The presence of ink in the ventricular system was considered evidence of a positive ventricular placement. MPOA cannula placements were determined independently by three investigators.
PRL Determinations. Plasma concentrations of PRL were measured by radioimmunoassay using the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) rPRL kit. The PRL assay kit includes the rPRL reference preparation (RP-3) and anti-rPRL (S-9). This assay has previously been validated in our laboratory (6) .
Statistical Analysis. Hormone data were analyzed by using an analysis of variance. Behavioral data were analyzed with the Kruskal-Wallis test for multiple group comparisons, the Mann-Whitney U test for comparisons between groups, and the Fisher test for exact probability (22) . Behavioral latencies are expressed in terms of cumulative percentage of animals responding over days and as medians. Experiment 1: I.c.v. Infusions of oPRL and the Induction of Maternal Behavior in Steroid-Treated, Nulliparous Rats. The objective of these studies was to determine which doses of oPRL when given i.c.v. might stimulate the onset of maternal behavior. In the initial i.c.v. studies the effects of two doses of oPRL on the induction of maternal behavior were examined. On day 1, one week after cannulations, females were started on the steroid hormone regimen. Between 1000 and 1100 hr on day 11, immediately after bromocriptine injections and changing Silastic implants, rats were infused i.c.v. with either oPRL or vehicle. One set of experimental rats (n = 10) was administered 50 ug of oPRL in 3.8 pLi, whereas a second set of females (n = 11) was given 10 jig of oPRL in 0.8 ,ul.
Separate control groups (n = 11 per group) were given 3.8 ,ul and 0.8 Mkl of vehicle, respectively.
In the final i.c.v. dose-response study, the effects of three lower doses of oPRL on maternal behavior were measured. Starting 1 week after cannulations, all females were treated with steroid hormones as previously described. After bromocriptine injections and capsule changing on treatment day 11, four groups ofrats (n = 8-11) were infused i. Fig. 1 , significantly more rats displayed full maternal behavior on test day 3 and 4 in the 50-pg oPRL group and on test days 3-6 in the 10-pug oPRL group versus their respective control group (P values < 0.05). Median latencies to display maternal behavior for the 50-pg and 10-ug oPRL treatment groups were 2.9 and 1.6 days, respectively, whereas the control values were 5.0 and 5.7 days. These data suggest a central role for PRL in the regulation of maternal behavior in the female rat.
The effects of smaller amounts of oPRL (80 ng-2 ug) on maternal behavior are shown in Fig. 2 latency of PRL-treated rats to display full maternal behavior was 3.5 days, whereas that of controls was 3.0 days. Plasma rat PRL levels in these groups were equally suppressed by bromocriptine. PRL levels measured in oPRL-and vehicleinjected rats on treatment day 17 were 5.6 ± 1.4 and 5.1 ± 0.8 ng/ml (mean ± SEM), respectively. That maternal behavior is not stimulated by systemic oPRL injections indicates that the rapid onset of maternal behavior induced by equal and lower i.c.v. doses of oPRL in experiment 1 Fig. 4 ). The median latencies to respond maternally were 1.3 days for the oPRL group and 5.6 days for vehicle controls. Significantly more rats treated with oPRL responded maternally from test day 2 through 6 (P values < 0.025 to < 0.005), with all PRL-treated females becoming maternal within the 6 test days. Histological examination revealed that the tips of the infusion cannulas were located either within the MPOA or in close proximity to this region (see Fig. 5 ). Thus, direct infusions of oPRL into the (17) , in the hypothalamus of rabbits and rats (14, 16) , and most recently in 'the MPOA of female rats (18) .
Since pituitary PRL appears essential for the rapid onset of maternal behavior in steroid-primed virgin rats, our present results demonstrating a central site of action for PRL suggest that circulating PRL reaches the CSF, the brain, and the MPOA in particular. Evidence increases in blood and CSF PRL levels in the mother rats (13) . CSF PRL concentrations are also higher at times of the reproductive cycle when females exhibit elevations in circulating PRL (11, 12) . Moreover, in male rats administration of haloperidol, a dopamine receptor antagonist that elevates peripheral PRL concentrations, increases CSF IR PRL concentrations (27) . Interestingly, basal levels of IR PRL in the CSF of these male rats prior to haloperidol treatment appear to be of neural origin, independent of the pituitary gland (27, 28) . Together, these data indicate that PRL, like other molecules (29) , can gain access to CSF by means of transport across the CSF-brain barrier. Once within the CSF, PRL in principle has access to numerous neural regions.
Physiological studies demonstrate that during the course of pregnancy rats are exposed to high circulating titers of PRL as well as other lactogenic hormones-i.e., growth hormone and placental lactogens (8, 9) . Interestingly, CSF concentrations of immunoreactive PRL are undetectable just prior to parturition (13) . One possible explanation to account for the lack of PRL in the CSF at this time is that the high levels of rat placental lactogen II prepartum (9) (30, 31) and estrogen receptors (32, 33) in the MPOA prepartum may help stimulate the onset of maternal behavior. E2 and P may stimulate synthesis of PRL receptors, receptors that can then bind endogenous PRL and PRL-like molecules and alter their access to the CSF at the level of the choroid plexus (10) or within the region of the MPOA. It is also possible that PRL is the agent responsible for the increase in estrogen receptors (34) , which then may allow estrogen to directly stimulate maternal behavior.
In addition to systemic PRL reaching the brain, it is also noteworthy that IR PRL, including messenger RNA for PRL, is found in neurons in the brain (28, (35) (36) (37) (38) (39) (40) , including the preoptic area, and that the brain PRL system, which is responsive to estrogen (41), appears to be distinct from the pituitary PRL system. One intriguing possibility is that this brain PRLlike system may be involved in the regulation of maternal behavior at times when peripherally produced lactogens are no longer required for the stimulation of maternal responsiveness. It is well recognized that once maternal behavior becomes established in female rats the behavior is maintained independent of pituitary regulation (42, 43) . Perhaps the brain/PRL system regulates maternal care at this time. It is possible that long-term alterations in anatomical and biochemical processes, similar to those that have been identified in the synaptic connectivity in the supraoptic nucleus offemale rats (44) , occur within the MPOA as a consequence of pregnancy and lactation. Some form of prolonged up-regulation ofthe brain/PRL system as a consequence of prior parity, for example, might free maternal behavior from peripheral endocrine control and be involved in the retention or remembering of maternal behavior in nonlactating parous animals (45) . It would be of interest to know whether in humans and other primates, species in which hormones appear to play a less critical role in inducing parental behavior, similar brain/hormonal systems become functional during development independent of pregnancy and lactation, which might modulate the expression of maternal care.
